Veterinary Dermatology Drugs Market Analysis

Veterinary Dermatology Drugs Market Analysis

To get key market trends

  Download Free Sample

Based on drug class, the market is categorized into antifungal drugs, antibacterial drugs, antiparasitic drugs, and other drug classes. The antibacterial drugs segment held the largest market share of 38.0% in 2022. Bacterial skin infections are common in pets, particularly dogs and cats. Bacteria such as Staphylococcus spp., Streptococcus spp., and Pseudomonas spp. can cause these diseases. As bacterial skin infections are so common, there is a strong demand for effective antibacterial medications in veterinary dermatology.
 

Based on indication, the veterinary dermatology drugs market is categorized into parasitic infections, autoimmune skin diseases, allergic infections, skin cancer, and other indications. The parasitic infections segment held the largest market share of 33.3% in 2022. Parasitic infections are widespread in animals, and they can cause a range of skin problems, including dermatitis, itching, and hair loss. The high prevalence of parasitic infections drives the demand for animal parasiticides.

Based on route of administration, the veterinary dermatology drugs market is bifurcated into injectable, topical, and oral. The oral segment was anticipated to be worth of USD 3.4 billion in 2022 and is expected to grow at 9.2% CAGR during the forecast period. Oral medications provide a systemic approach to dermatological disorders, allowing the medication to circulate through the circulation and address the underlying source of the problem. They are frequently selected due to their potency and ease, as they may be taken orally and do not require external administration. In addition to this, oral route has higher compliance in animals which ensures the consistent intake of medications, leading to better treatment outcomes.
 

Based on animal type, the veterinary dermatology drugs market is classified into companion animal and livestock animal. The companion animal is further divider into dogs, cats, horses, and other companion animals. The livestock animal is further divider into bovine, swine, and other livestock animals. The companion animal segment held dominant market share of 60.6% in 2022 and is expected to grow at a significant pace of 9.6% during the forecast period. The increasing number of pet owners and the growing trend of pet humanization have led to a larger population of companion animals. As more pets become part of households, there is a higher demand for veterinary services and medications, including dermatology drugs.
 

Based on distribution channel, the veterinary dermatology drugs market is classified into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment held dominant market share of around 56.5% in 2022. Hospital pharmacies stock a wide range of dermatology drugs to manage various skin issues in animals, including bacterial, fungal, and parasitic infections. The availability of these medications ensures timely and effective treatment of dermatological conditions.
 

North America veterinary dermatology drugs market accounted for significant revenue in 2022 and is expected to reach USD 6.9 billion in 2032 with a CAGR of 9.3% from 2023-2032. North America has a significant number of veterinary dermatology specialists who focus on diagnosing and treating skin conditions in animals. The availability of specialized care drives the demand for specific dermatology drugs in the region. In addition, the region's strong research and development efforts in veterinary medicine have led to advancements in dermatology drugs. The introduction of new and improved formulations enhances the treatment options available for veterinarians.
 

Moreover, the trend of pet humanization, where pets are considered part of the family, is increasing in North America. Pet owners are willing to invest in their pets' health and well-being, leading to a higher demand for advanced veterinary dermatology drugs to address skin issues.